XML 77 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation (Tables)
9 Months Ended
Mar. 31, 2014
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense

 

Stock
Options
FY 2014

 

Stock
Options
FY 2013

 

Risk-free interest rate

 

2.1

%

1.0

%

Expected volatility

 

62.9

%

61.5

%

Expected dividend yield

 

0.0

%

0.0

%

Forfeiture rate

 

7.5

%

7.5

%

Expected term (in years)

 

5.9 years

 

6.1 years

 

Weighted average fair value

 

$8.14

 

$2.36

 

Summary of stock option award activity

 

(In thousands, except for weighted average price and life data)

 

Awards

 

Weighted-
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life (yrs.)

 

Outstanding at July 1, 2013

 

2,319

 

$

5.71

 

 

 

 

 

Granted

 

770

 

$

13.97

 

 

 

 

 

Exercised

 

(718

)

$

6.15

 

$

22,373

 

 

 

Forfeited, expired or repurchased

 

(105

)

$

16.27

 

 

 

 

 

Outstanding at March 31, 2014

 

2,266

 

$

7.89

 

$

63,070

 

7.5

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at March 31, 2014

 

2,152

 

$

7.73

 

$

60,234

 

7.4

 

Exercisable at March 31, 2014

 

902

 

$

5.27

 

$

27,464

 

5.5

 

Summary of nonvested restricted stock awards

 

(In thousands)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

Non-vested at July 1, 2013

 

 

 

 

 

Granted

 

245

 

23.03

 

 

 

Vested

 

(63

)

18.79

 

$

1,175

 

Forfeited

 

 

 

 

 

Non-vested at March 31, 2014

 

182

 

$

24.48

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

March 31,

 

March 31,

 

(In thousands)

 

2014

 

2013

 

2014

 

2013

 

Selling, general and administrative

 

$

2,240

 

$

200

 

$

4,763

 

$

975

 

Research and development

 

225

 

23

 

443

 

75

 

Cost of sales

 

324

 

29

 

627

 

142

 

Total

 

2,789

 

252

 

5,833

 

1,192

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

1,053

 

$

42

 

$

2,160

 

$

99